Aerpio Pharmaceuticals
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Aerpio Pharmaceuticals's balance sheet done over the years? Its assets were worth $95,834,000 last year, which is more than in the previous period. 62% of Aerpio Pharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $59,754,000, which means an increase by 35% compared compared to last year.

Debt to Assets

Aerpio Pharmaceuticals, Inc. (NASDAQ:ARPO): Debt to assets
2011 6625 74.80K 1129.07%
2017 26245000 758K 2.89%
2018 14545000 2.03M 13.97%
2019 25451000 10.85M 42.66%
2020 39516000 20.65M 52.28%
2021 69768000 44.37M 63.6%
2022 95834000 59.75M 62.35%

ARPO Balance Sheet (2011 – 2022)

2022 2021 2020 2019 2018 2017 2011
Assets
Current assets:
Cash and cash equivalents
14.85M10.28M9.64M6.03M9.66M11.37M4.12K
Short term investments
000009.65M0
Net receivables
0000000
Inventory
0000000
Other current assets
12.19M4.70M1.19M621.99K696.99K360K2.5K
Total current assets
27.04M14.99M10.84M6.65M10.36M21.38M6.62K
Non-current assets:
Property, Plant and Equipment
46.65M38.07M12.83M4.21M3.24M3.82M0
Goodwill
3.49M3.49M3.49M3.49M000
Intangible assets
0000000
Long term investments
0000000
Other non-current assets
-50.14M-41.56M-16.32M-7.70M-3.24M-3.82M0
Total non-current assets
50.14M41.56M16.32M7.70M3.24M3.82M0
Total assets
95.83M69.76M39.51M25.45M14.54M26.24M6.62K
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
0000000
Short term debt
00000060K
Total current liabilities
24.87M4.81M6.70M4.87M2.03M758K74.80K
Non-current liabilities:
Long term debt
00000060K
Deferred tax
0000000
Other non-current liabilities
0000000
Total non-current liabilities
00000060K
Total liabilities
59.75M44.37M20.65M10.85M2.03M758K74.80K
Data source